Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies.

Cai, Tiantian; Zhao, Jing; Yang, Yanping; Jiang, Yanfei; Zhang, Jin-An

Cai, Tiantian; Zhao, Jing; Yang, Yanping; Jiang, Yanfei; Zhang, Jin-An.

Afiliação

Cai T; Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, People's Republic of China.
Zhao J; Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Yang Y; Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, People's Republic of China.
Jiang Y; Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, People's Republic of China.
Zhang JA; Department of Endocrinology & Rheumatology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, People's Republic of China.

Lupus ; 31(14): 1714-1725, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36325952

Assuntos

Antirreumáticos; Lúpus Eritematoso Sistêmico; Humanos; Hidroxicloroquina/uso terapêutico; Lúpus Eritematoso Sistêmico/complicações; Antirreumáticos/uso terapêutico; Cloroquina/uso terapêutico; Estudos de Coortes

Palavras-chave

Hydroxychloroquine; cohort studies; meta-analysis; mortality; systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antirreumáticos / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antirreumáticos / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article